Published in Nephron on January 01, 1975
End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen. J Clin Invest (1990) 1.66
Human protein HC and its IgA complex are inhibitors of neutrophil chemotaxis. Proc Natl Acad Sci U S A (1986) 1.13
Tuberculin skin test for the diagnosis of latent tuberculosis during renal replacement therapy in an endemic area: A single center study. Indian J Nephrol (2010) 1.03
Effects of parathyroid hormone on immune function. Clin Dev Immunol (2010) 0.86
Post-transplant monitoring of renal allograft recipients for T, B and null lymphocyte subpopulations. Clin Exp Immunol (1977) 0.84
T-lymphocyte number and function and the course of hepatitis B in hemodialysis patients. Infect Immun (1976) 0.83
Evaluation of antibody response to the heptavalent pneumococcal conjugate vaccine in pediatric chronic kidney disease. Pediatr Nephrol (2008) 0.80
Immune defects in chronic renal impairment: evidence for defective regulation of lymphocyte response by macrophages from patients with chronic renal impairment on haemodialysis. Clin Exp Immunol (1986) 0.80
Value of the tuberculin skin testing and of an interferon-gamma release assay in haemodialysis patients after exposure to M. tuberculosis. BMC Infect Dis (2012) 0.79
Thymus lymphocytes in uraemic rats and the effect of thymosin fraction 5 in vitro. Clin Exp Immunol (1990) 0.78
Immunogenicity of low-dose MF59-adjuvanted 2009 influenza A/H1N1 vaccine in dialysis patients. Clin Exp Nephrol (2012) 0.77
Disseminated cryptococcosis in a patient receiving chronic haemodialysis. Postgrad Med J (1985) 0.77
Immunosuppressive factors in uraemic sera are composed of both dialysable and non-dialysable components. Clin Exp Immunol (1983) 0.75
Comparison of interferon gamma release assay & tuberculin skin tests for diagnosis of latent tuberculosis in patients on maintenance haemodialysis. Indian J Med Res (2015) 0.75
Antibody production and antigenic specific suppression to bovine serum albumin in uremic rats. Clin Exp Immunol (1982) 0.75
Active T and EA-rosette-forming cells in human cadaver renal allograft recipients. Clin Exp Immunol (1979) 0.75
The renal medulla and mechanisms of hypertension in the spontaneously hypertensive rat. Am J Pathol (1976) 0.75
Matrix metalloproteinase levels in peritoneal effluents were increased in a patient with appendicitis undergoing continuous ambulatory peritoneal dialysis. Clin Exp Nephrol (2011) 0.75
Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group. Transplantation (1999) 2.81
High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J Exp Med (1994) 2.70
A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy. AIDS (1999) 2.54
A new method of preparation of segmental pancreatic grafts for transplantation: trials in dogs and in man. Surgery (1978) 2.27
Twenty-five years of experience with out-center hemodialysis. Kidney Int (1999) 2.24
Carboplatin-etoposide combination in small cell lung cancer patients older than 70 years: a phase II trial. Lung Cancer (2002) 2.12
Reactivity pattern of a monoclonal antikeratin antibody (KL1). J Invest Dermatol (1983) 1.98
Phorbol myristate acetate: a mitogen selective for a T-lymphocyte subpopulation. J Exp Med (1977) 1.91
Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells. J Clin Invest (1998) 1.79
The immunocytochemical detection of axillary micrometastases in breast cancer. Br J Cancer (1984) 1.77
Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia. Blood (1991) 1.73
Mechanisms involved in antithymocyte globulin immunosuppressive activity in a nonhuman primate model. Transplantation (2001) 1.68
Murine enterocytes can present soluble antigen to specific class II-restricted CD4+ T cells. Eur J Immunol (1989) 1.63
External anogenital lesions in organ transplant recipients. A clinicopathologic and virologic assessment. Arch Dermatol (1997) 1.53
Distribution of cells binding erythrocyte-antibody (EA) complexes in human lymphoid populations. Scand J Immunol (1976) 1.53
Expression, function and regulation of the intercellular adhesion molecule-1 (ICAM-1) on human intestinal epithelial cell lines. Eur J Immunol (1991) 1.49
Major histocompatibility complex class I-restricted CD8+ T cells and class II-restricted CD4+ T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzene. Eur J Immunol (1995) 1.47
Immunological aspects of psoriasis. II. Dissociated impairment of thymus-dependent lymphocytes. Br J Dermatol (1976) 1.44
Randomised, double-blind, placebo-controlled trial of ditiocarb sodium ('Imuthiol') in human immunodeficiency virus infection. Lancet (1988) 1.43
Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma. Eur Cytokine Netw (1991) 1.42
Heterologous specific antiserum for identification of human T lymphocytes. Clin Exp Immunol (1974) 1.40
Biologic effects of anti-interleukin-6 murine monoclonal antibody in advanced multiple myeloma. Blood (1995) 1.39
Defective synthesis of HbE is due to reduced levels of beta E mRNA. Nature (1980) 1.38
[The Lady Windermere syndrome: clinical and bacteriological data and progress in seven cases]. Rev Mal Respir (2012) 1.38
Antigen recognition by MHC-incompatible cells of a human mismatched chimera. J Exp Med (1988) 1.35
The myeloma cell antigen syndecan-1 is lost by apoptotic myeloma cells. Br J Haematol (1998) 1.33
A human T-independent B lymphocyte mitogen extracted from Nocardia opaca. J Immunol (1976) 1.33
Sex steroid receptors in peripheral T cells: absence of androgen receptors and restriction of estrogen receptors to OKT8-positive cells. J Immunol (1983) 1.30
Changes of Fcgamma receptor-related properties induced by interaction of human lymphocytes with insoluble immune complexes. J Immunol (1977) 1.30
Study of human T and B lymphocytes with heterologous antisera. I Preparation, specificity and properties of antisera. Immunology (1976) 1.29
Differentiation of human bone marrow cells into T lymphocytes by in vitro incubation with thymic extracts. Clin Exp Immunol (1974) 1.29
Intestinal microsporidiosis occurring in two renal transplant recipients treated with mycophenolate mofetil. Transplantation (1999) 1.27
A gp130 interleukin-6 transducer-dependent SCID model of human multiple myeloma. Blood (1998) 1.27
Serum beta2-microglobulin in hemodialyzed patients. Nephron (1978) 1.23
Endocrine responses of type 1 (insulin-dependent) diabetic patients following successful pancreas transplantation. Diabetologia (1983) 1.22
Insulin-like growth factor induces the survival and proliferation of myeloma cells through an interleukin-6-independent transduction pathway. Br J Haematol (2000) 1.21
Peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) produce reduced levels of interleukin-4, interleukin-2 and interferon-gamma, but proliferate normally upon activation by mitogens. Clin Exp Immunol (1989) 1.21
The Mi15 monoclonal antibody (anti-syndecan-1) is a reliable marker for quantifying plasma cells in paraffin-embedded bone marrow biopsy specimens. Hum Pathol (1999) 1.20
Combined immunodeficiency disease associated with absence of cell-surface HLA-A and -B antigens. J Pediatr (1978) 1.19
Cytomegalovirus infection--an etiological factor for rejection? A prospective study in 242 renal transplant patients. Transplantation (1993) 1.18
Induction of Fas (Apo-1, CD95)-mediated apoptosis of activated lymphocytes by polyclonal antithymocyte globulins. Blood (1998) 1.18
High amounts of circulating interleukin (IL)-6 in the form of monomeric immune complexes during anti-IL-6 therapy. Towards a new methodology for measuring overall cytokine production in human in vivo. Eur J Immunol (1992) 1.17
Malignant hypertension with irreversible renal failure due to oral contraceptives. Br Med J (1975) 1.16
Autoreactive T cell clones specific for class I and class II HLA antigens isolated from a human chimera. J Exp Med (1988) 1.16
Distribution of androgen and estrogen receptors among lymphoid and haemopoietic cell lines. Leuk Res (1985) 1.15
Suppression of mitogen-induced peripheral B cell differentiation by soluble Fc gamma receptors released from lymphocytes. Eur J Immunol (1980) 1.14
Pharmacokinetics, foreign protein immune response, cytokine release, and lymphocyte subsets in patients receiving thymoglobuline and immunosuppression. Transplant Proc (1997) 1.14
Kinetics of plasma membrane and mitochondrial alterations in cells undergoing apoptosis. Cytometry (1995) 1.13
Sialadenitis in nonobese diabetic mice: transfer into syngeneic healthy neonates by splenic T lymphocytes. Clin Immunol Immunopathol (1991) 1.12
Anti-beta2-microglobulin lymphocytotoxic autoantibodies in systemic lupus erythematosus. J Immunol (1979) 1.10
[Aluminum poisoning in renal dialysis patients: bone histology. Value of quantitative bone biopsy]. Presse Med (1984) 1.10
Age-dependent changes of human blood lymphocyte subpopulations. Clin Exp Immunol (1978) 1.10
T-dependence of human B lymphocyte proliferative response to mitogens. Int Arch Allergy Appl Immunol (1976) 1.09
Unexpected lack of reactivity of allogeneic anti-Ia monoclonal antibodies with MHC class II molecules expressed by mouse intestinal epithelial cells. J Immunol (1993) 1.09
Tumor necrosis factor is a survival and proliferation factor for human myeloma cells. Eur Cytokine Netw (1999) 1.08
Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression. Transplantation (2001) 1.08
Study of human T and B lymphocytes with heterologous antisera. III. Immunofluorescence studies on tonsil sections. Immunology (1978) 1.08
Immunodeficiency diseases and expression of HLA antigens. Hum Immunol (1981) 1.07
Antibodies against functional leukocyte surface molecules in polyclonal antilymphocyte and antithymocyte globulins. Transplantation (1991) 1.07
[Very severe colibacillus meningitis complicating post-abortum acute renal failure. Cure by ampicillin]. Lyon Med (1967) 1.06
Antibody-dependent cell cytoxicity (ADCC). Characterization of 'killer' cells in human lymphoid organs. Scand J Immunol (1976) 1.06
Mechanisms of action of methotrexate. Immunopharmacology (2000) 1.05
Plasma bioavailable interleukin-6 is elevated in human immunodeficiency virus-infected patients who experience herpesvirus-associated immune restoration disease after start of highly active antiretroviral therapy. J Infect Dis (2001) 1.05
First human hand transplantation. Case report. Transpl Int (2000) 1.05
Beta 2-microglobulin-associated amyloidosis in chronic haemodialysis patients. Lancet (1986) 1.04
Enhancement of T-lymphocyte differentiation in vitro by thymic extracts after bone marrow transplantation in severe combined immunodeficiencies. Clin Immunol Immunopathol (1975) 1.04
Cooperation between major histocompatibility complex mismatched mononuclear cells from a human chimera in the production of antigen-specific antibody. J Clin Invest (1986) 1.04
Natural killer cells in Behçet's disease. Clin Exp Immunol (1988) 1.04
Activity of a new high efficiency diuretic in man: piretanide (HOE 118). Br J Clin Pharmacol (1980) 1.03
Detection of virus-specific IgA antibodies in serum of kidney transplant patients with recurrent cytomegalovirus infection by enzymeimmuno and radioimmunoassay techniques. Clin Exp Immunol (1982) 1.02
Studies of anti-lymphocyte globulins made from thoracic duct lymphocytes. Transplant Proc (1969) 1.02
IFN-alpha is a survival factor for human myeloma cells and reduces dexamethasone-induced apoptosis. J Immunol (1998) 1.01
The animal lectin galectin-3 interacts with bacterial lipopolysaccharides via two independent sites. J Immunol (1996) 1.01
Sequential stages of human T lymphocyte differentiation. Proc Natl Acad Sci U S A (1977) 1.00
Caspase-dependent ceramide production in Fas- and HLA class I-mediated peripheral T cell apoptosis. J Biol Chem (1998) 1.00
Detection of specific IgA antibodies in serum of kidney transplant patients with recurrent cytomegalovirus infection. Intervirology (1981) 1.00
Active and passive re-expression of Fc gamma receptors on human lymphocytes. Eur J Immunol (1980) 1.00
Multiple sclerosis-associated retrovirus particles cause T lymphocyte-dependent death with brain hemorrhage in humanized SCID mice model. J Neurovirol (2003) 0.99
[Furosemide and renal failure. I. Use during acute renal failure]. Lyon Med (1971) 0.99
Inhibition of the mixed lymphocyte reaction by antibodies. Transplant Proc (1972) 0.99
Selective suppression of human B lymphocyte differentiation into IgG-producing cells by soluble Fc gamma receptors. J Immunol (1982) 0.99
[Use in man of an anti-lymphocyte globulin: clincial results in renal transplantation]. Lyon Med (1968) 0.99
Insoluble immune complexes suppress mitogen-induced proliferation of human T lymphocytes bearing Fc gamma receptors. Cell Immunol (1979) 0.99